Form 4: Arteris CEO Sells $1.4M in Stock Under 10b5-1 Plan
Insider Trading Report
Arteris, Inc. President and CEO, Janac K Charles, sold over 105,000 shares of common stock for approximately $1.4 million through a pre-arranged 10b5-1 trading plan.
Summary
- Janac K Charles, President and CEO and a 10% owner of Arteris, Inc., reported the sale of 105,755 shares of common stock.
- The transactions occurred on October 6, 2025, under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025.
- A total of 5,755 shares were sold at a price of $14.00 per share.
- An additional 100,000 shares were sold at a weighted average price of $13.1045 per share, with individual sales ranging from $12.50 to $13.85.
- The total value of shares sold amounts to approximately $1,399,950.
- Following these transactions, Janac K Charles directly beneficially owns 161,759 shares and indirectly owns 9,739,071 shares through Bayview Legacy, LLC, and 56,252 shares through Charles and Lydia Janac Trust.
Sentiment
Score: 4
Explanation: The insider selling by the CEO and 10% owner is a yellow flag, but the execution under a pre-arranged 10b5-1 plan mitigates some of the immediate negative sentiment, suggesting a planned liquidity event rather than an opportunistic sale based on new negative information.
Positives
- The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than an opportunistic one based on non-public information.
Negatives
- The President and CEO, also a 10% owner, sold a significant number of shares, which can be perceived by the market as a lack of confidence or a move to diversify holdings.
Risks
- No specific risks are detailed in this Form 4 filing beyond the general market perception of insider selling.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing, an insider transaction report, does not provide information directly related to broader industry trends or competitors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Adoption | The reporting person adopted a Rule 10b5-1 trading plan on March 5, 2025, under which these transactions were executed. | March 5, 2025 | Enhances transparency and mitigates concerns about opportunistic insider trading by pre-scheduling sales. |
Related Party Transactions
- The reporting person's indirect beneficial ownership includes shares held by Bayview Legacy, LLC, for which the reporting person is the manager, and shares held by Charles and Lydia Janac Trust, for which the reporting person serves as trustee.
Stakeholder Impact
- Shareholders may interpret the CEO's sale of shares as a negative signal regarding future company performance or valuation.
- The pre-arranged nature of the 10b5-1 plan may mitigate some of these concerns by indicating a planned liquidity event rather than a reaction to new, negative information.
Key Dates
| Date | Description |
|---|---|
| March 5, 2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| October 6, 2025 | Date of the reported stock transactions. |
| October 8, 2025 | Date the Form 4 was signed by the Reporting Person's Attorney-in-Fact. |
Recommendation
holdWhile the President and CEO sold a notable amount of shares, the transaction was executed under a pre-arranged 10b5-1 trading plan, which suggests a planned diversification or liquidity event rather than an immediate reaction to negative company performance. Investors should monitor future filings and company performance for further insights, but this single event, while a yellow flag, does not warrant an immediate 'sell' recommendation without additional context.
Keywords
Arteris, AIP, insider trading, Form 4, stock sale, CEO, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.